Showing results (31-40 of 227) with videos related to
Sort By:
Pageof 23
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1986
Opioid activity and distribution of fentanyl metabolitesE Schneider, K BruneBiopharmaceutics & Drug Disposition|July 1, 1989
Buffering the stomach content enhances the absorption of diflunisal in manB Nuernberg, K BruneWiener Klinische Wochenschrift|March 27, 1999
[Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances]B Hinz, K BruneClinical and Experimental Rheumatology|November 7, 2001
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspectiveK Brune, A NeubertThe Journal of Pharmacy and Pharmacology|November 1, 1983
Inhibition of prostaglandin E2 release by salicylates, benzoates and phenols: a quantitative structure-activity studyJ Habicht, K BruneThe Biochemical Journal|March 15, 1981
Dissociation of tumour-promoter-induced effects on prostaglandin release, polyamine synthesis and cell proliferation of 3T3 cellsR Lanz, K BruneCurrent Opinion in Anaesthesiology|October 4, 2006
New insights into physiological and pathophysiological functions of cyclo-oxygenase-2B Hinz, K BruneNaunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1985
Distribution of fentanyl in rats: an autoradiographic studyE Schneider, K BrunePageof 23